

Sinopharm Group (OTCMKTS:SHTDY - Get Free Report) and Pediatrix Medical Group (NYSE: MD - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability. Analyst Recommendations This is a breakdown of

Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Positive high-level results from the Phase III CROSSING trial in patients with eosinophilic esophagitis (EoE) showed that AstraZeneca and Amgen's TEZSPIREÂ (te

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results despite lower volumes.